Payment overview · 2025
General Payments
$36.49
2 reported records · 2 companies
Healthcare provider profile · identity verified
Paramjit Sikand, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · JOLIET, IL · NPI 1902875628
Verified facts
What the public records show
CMS Open Payments records show Paramjit Sikand, M.D. received $36.49 in general payments during 2025 across 2 reported records.
SANOFI PASTEUR INC. accounted for 61.2% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 4 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| SANOFI PASTEUR INC. | Unresolved — no canonical attribution shown | $22.34 | 61.2% | 1 | 2025 |
| Aimmune Therapeutics, Inc. | Unresolved — no canonical attribution shown | $14.15 | 38.8% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $36.49 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| BEYFORTUS Normalized: beyfortus |
Biological | SANOFI PASTEUR INC. | $22.34 | 1 | 2025 |
Source payment records
|
|||||
| FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE Normalized: flublok quadrivalent northern hemisphere |
Biological | SANOFI PASTEUR INC. | $22.34 | 1 | 2025 |
Source payment records
|
|||||
| FLUZONE HIGH-DOSE Normalized: fluzone high dose |
Biological | SANOFI PASTEUR INC. | $22.34 | 1 | 2025 |
Source payment records
|
|||||
| ZENPEP Normalized: zenpep |
Drug | Aimmune Therapeutics, Inc. | $14.15 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 392 | 105 |
| Amlodipine Besylate | Amlodipine Besylate | 365 | 100 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 312 | 52 |
| Metformin Hcl | Metformin Hcl | 262 | 74 |
| Losartan Potassium | Losartan Potassium | 254 | 66 |
| Lisinopril | Lisinopril | 239 | 71 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 232 | 69 |
| Pantoprazole Sodium | Pantoprazole Sodium | 217 | 64 |
| Gabapentin | Gabapentin | 190 | 43 |
| Alprazolam | Alprazolam | 158 | 26 |
| Furosemide | Furosemide | 142 | 37 |
| Hydrochlorothiazide | Hydrochlorothiazide | 139 | 46 |
| Fluticasone Propionate | Fluticasone Propionate | 134 | 49 |
| Metoprolol Succinate | Metoprolol Succinate | 114 | 32 |
| Metoprolol Tartrate | Metoprolol Tartrate | 111 | 23 |
| Levothyroxine Sodium | Levothyroxine Sodium | 110 | 36 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 106 | 26 |
| Simvastatin | Simvastatin | 100 | 25 |
| Alendronate Sodium | Alendronate Sodium | 91 | 22 |
| Carvedilol | Carvedilol | 90 | 26 |
| Omeprazole | Omeprazole | 88 | 29 |
| Tramadol Hcl | Tramadol Hcl | 88 | 16 |
| Hydralazine Hcl | Hydralazine Hcl | 84 | 19 |
| Potassium Chloride | Potassium Chloride | 84 | 30 |
| Glipizide | Glipizide | 83 | 22 |
| Lovastatin | Lovastatin | 83 | 26 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 81 | 26 |
| Clopidogrel | Clopidogrel Bisulfate | 78 | 22 |
| Eliquis | Apixaban | 78 | 21 |
| Allopurinol | Allopurinol | 77 | 16 |
| Montelukast Sodium | Montelukast Sodium | 65 | 15 |
| Tamsulosin Hcl | Tamsulosin Hcl | 62 | 18 |
| Symbicort | Budesonide/Formoterol Fumarate | 61 | 19 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 58 | 14 |
| Duloxetine Hcl | Duloxetine Hcl | 52 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 51 | 16 |
| Ozempic | Semaglutide | 50 | 11 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 49 | 18 |
| Amoxicillin | Amoxicillin | 48 | 38 |
| Januvia | Sitagliptin Phosphate | 47 | 12 |
| Zolpidem Tartrate | Zolpidem Tartrate | 46 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 45 | suppressed |
| Levetiracetam | Levetiracetam | 45 | suppressed |
| Desloratadine | Desloratadine | 41 | suppressed |
| Ezetimibe | Ezetimibe | 41 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 40 | 27 |
| Enalapril Maleate | Enalapril Maleate | 34 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 34 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 32 | 14 |
| Jardiance | Empagliflozin | 31 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 28 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 27 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 25 | 18 |
| Glimepiride | Glimepiride | 24 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 24 | suppressed |
| Sertraline Hcl | Sertraline Hcl | 24 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 23 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 23 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 22 | suppressed |
| Hydrocortisone | Hydrocortisone | 21 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 21 | suppressed |
| Clonazepam | Clonazepam | 20 | suppressed |
| Finasteride | Finasteride | 20 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 20 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 19 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 19 | suppressed |
| Escitalopram Oxalate | Escitalopram Oxalate | 19 | suppressed |
| Pregabalin | Pregabalin | 19 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 19 | suppressed |
| Famotidine | Famotidine | 18 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 18 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 18 | suppressed |
| Trazodone Hcl | Trazodone Hcl | 18 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 18 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 18 | suppressed |
| Cephalexin | Cephalexin | 17 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 17 | suppressed |
| Erythromycin | Erythromycin Base | 16 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 16 | suppressed |
| Lamotrigine | Lamotrigine | 16 | suppressed |
| Linzess | Linaclotide | 16 | suppressed |
| Naproxen | Naproxen | 16 | suppressed |
| Temazepam | Temazepam | 16 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 15 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 15 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 15 | suppressed |
| Trulicity | Dulaglutide | 15 | suppressed |
| Atenolol | Atenolol | 14 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 14 | suppressed |
| Fosinopril Sodium | Fosinopril Sodium | 14 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 14 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 14 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 14 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 14 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 14 | suppressed |
| Alcohol Prep Pads | Alcohol Antiseptic Pads | 13 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 13 | suppressed |
| Fenofibrate | Fenofibrate | 13 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 13 | suppressed |
| Phenobarbital | Phenobarbital | 13 | suppressed |
| Spironolactone | Spironolactone | 13 | suppressed |
| Bupropion Xl | Bupropion Hcl | 12 | suppressed |
| Ibuprofen | Ibuprofen | 12 | suppressed |
| Novolin N Flexpen | Insulin Nph Human Isophane | 12 | suppressed |
| Isosorbide Mononitrate | Isosorbide Mononitrate | 11 | suppressed |
| Levemir Flexpen | Insulin Detemir | 11 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 11 | suppressed |
| Mounjaro | Tirzepatide | 11 | suppressed |
| Novolog | Insulin Aspart | 11 | suppressed |
| Ofloxacin | Ofloxacin | 11 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 11 | suppressed |
| Tradjenta | Linagliptin | 11 | suppressed |
| Xarelto | Rivaroxaban | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $36.49 · 2 records | SANOFI PASTEUR INC. | BEYFORTUS, FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE, FLUZONE HIGH-DOSE, ZENPEP | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error